Search

Your search keyword '"Gulik, Thomas M."' showing total 184 results

Search Constraints

Start Over You searched for: Author "Gulik, Thomas M." Remove constraint Author: "Gulik, Thomas M." Publisher elsevier bv Remove constraint Publisher: elsevier bv
184 results on '"Gulik, Thomas M."'

Search Results

1. The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trial

2. Relief of symptoms and quality of life after conservative versus surgical treatment of benign liver tumors (CONSULT): a retrospective propensity score matched study

3. Long-term follow-up of a randomized trial of biliary drainage in perihilar cholangiocarcinoma

4. Success, complication, and mortality rates of initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma

5. Defining Textbook Outcome in liver surgery and assessment of hospital variation: A nationwide population-based study

7. Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study

8. Primary and secondary liver failure after major liver resection for perihilar cholangiocarcinoma

9. Surgical morbidity in the first year after resection for perihilar cholangiocarcinoma

10. Goal-directed fluid therapy vs. low central venous pressure during major open liver resections (GALILEO): a surgeon- and patient-blinded randomized controlled trial

11. International multicenter propensity score matched study on laparoscopic versus open left lateral sectionectomy

13. Case-mix adjustment to compare nationwide hospital performances after resection of colorectal liver metastases

15. Should jaundice preclude resection in patients with gallbladder cancer? Results from a nation-wide cohort study

17. Hepatopancreatoduodenectomy –a controversial treatment for bile duct and gallbladder cancer from a European perspective

20. Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center

22. Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules

23. Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis

26. Impact of expanding indications on surgical and oncological outcome in 1434 consecutive pancreatoduodenectomies

27. The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusion

29. 195 – Comparison of Short- and Long-Term Outcomes Between Anatomical Subtypes of Resected Biliary Tract Cancer in a Western High-Volume Center

30. Scintigraphic liver function and transient elastography in the assessment of patients with resectable hepatocellular carcinoma

33. Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial

36. Fluid and pain management in liver surgery (MILESTONE): A worldwide study among surgeons and anesthesiologists

39. Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial

40. Surgeons' assessment versus risk models for predicting complications of hepato-pancreato-biliary surgery (HPB-RISC): a multicenter prospective cohort study

41. Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: a nationwide audit

42. Long-term follow-up and risk factors for strictures after hepaticojejunostomy for bile duct injury: An analysis of surgical and percutaneous treatment in a tertiary center

43. Does portal vein embolization prior to liver resection influence the oncological outcomes – A propensity score matched comparison

44. The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma

46. Validation of the Mayo Clinic Staging System in Determining Prognoses of Patients With Perihilar Cholangiocarcinoma

47. Conditional survival in patients with unresectable perihilar cholangiocarcinoma

Catalog

Books, media, physical & digital resources